Abstract
An analysis of the taxonomic composition of 6,496 samples of plants collected for the National Cancer Institute is conducted and the results are presented. The results show that collecting has been highly biased towards woody plant families, as these species are often abundant, they yield samples of multiple parts, and it is often easy to collect sufficient material for isolation of chemicals present in low concentration. Conversely, herbaceous plants that are small or grow in sparse populations are underrepresented in collections. Three of the ten generically most diverse families in Madagascar have not been sampled, and of these ten families, only Rubiaceae and Euphorbiaceae have had greater numbers of samples collected than predicted if collecting was random. The causes of this bias are discussed, and solutions to ensure that bioprospecting efforts gather samples reflective of the diversity present are presented.
Zusammenfassung
Une analyze de la composition taxonomique de 6496 échantillons recoltés pour le National Cancer Institute est conduite et les resultants obtenus montrent que la récolte a été foretment biaisée, tendant pour une forte proportion des families des plantes ligneuses don’t les espèces sont souvent abondantes, peuvent fournir plusieurs sortes d’échantillon et souvent permettent facilement de collecter suffisament des matérielles pour l’isolation des composes chimiques presents à faible concentration. Contrairement, les plantes herbacées que sont de petites tailles our qui poussent avec des populations clairsemées sont sous representées dans les collections. Trois parmi les dix families génériquement les plus diversifies n’ont pas été recoltées, et de ces dix families, seules les Rubiaceae el les Euphorbiaceae ont eu les plus grands nombres d’échantillons que prévus si la récolte a été fait au hazard. Les cause de cette disproportion sont discutées et les solutions pour assurer que les efforts de bioprospection rassemblent des échantillons reflétant la diversité présente sont presentées.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Literature Cited
Airy-Shaw, H. K. 1973. A dictionary of the flowering plants and ferns. Cambridge University Press, Cambridge, U.K.
Balick, M. J. 1990. Ethnobotany and the identification of therapeutic agents from the rainforest. Pages 22–39 in D. J. Chadwick and J. Marsh, eds. Bioactive compounds from plants. Ciba Foundation Symposium 154, Wiley, Chichester.
Barclay, A. S., andR. E. Perdue. 1976. Distribution of anticancer activity in higher plants. Cancer Treatment Reports 60:1081–1114.
Caporale, L. H. 1995. Chemical ecology: A view from the pharmaceutical industry. Proceedings of the National Academy of Sciences of the United States of America 92:75–82.
Cox, P. A. 1990. Ethnopharmacology and the search for new drugs. Pages 40–55 in D. J. Chadwick and J. Marsh, eds. Bioactive compounds from plants. Ciba Foundation Symposium 154, Wiley, Chichester.
Cragg, G. M., M. R. Boyd, J. H. Cardellina II, M. R. Grever, S. A. Shepartz, K. M. Snader, andM. Stiffness. 1993. Role of plants in the National Cancer Institute drug discovery and development program. Pages 80–95 in A. D. Kinghorn and M. F. Balandrin, eds. Human medicinal agents from plants. American Chemical Society Symposium Series 534, American Chemical Society, Washington, D.C.
-, -,M. R. Grever,T. D. Mays,D. J. Newman, andS. A. Shepartz. 1994. Natural product drug discovery and development at the National Cancer Institute. Policies for international collaboration and compensation. Pages 221–232 in R. P.Adams, J. S. Miller, E. M. Golenberg, and J. E. Adams, eds. Conservation of plant genes II: Utilization of ancient and modern DNA. Monographs in Systematic Botany from the Missouri Botanical Garden 48.
—, —,M. R.Grever, and S. A. Shepartz. 1995. Pharmaceutical prospecting and the potential for pharmaceutical crops. Natural product drug discovery and development at the United States National Cancer Institute. Annals of the Missouri Botanical Garden 82:47–53.
Dejardin, J., J.-L. Guillaumet, and G. Mangenot. 1973. Contribution a la connaissance de 1’element non endemique de la flore malgache (Vegetaux vasculaires). Candollea 28:325–391.
Du Puy, D., P. Cribb, J. Bosser, J. Hermans, and C. Hermans. 1999. The orchids of Madagascar. Royal Botanic Gardens, Kew, UK.
Farnsworth, N. R. 1994. Ethnopharmacology and drug development. Pages 42–59 in D. J. Chadwick and J. Marsh, eds. Ethnobotany and the search for new drugs. Ciba Foundation Symposium 185, John Wiley and Sons, Chichester.
—,O. Akerele, A. S. Bingel, D. D. Soejarto, and Z. Guo. 1985. Medicinal plants in therapy. Bulletin of the World Health Organization 63(6): 965–981.
Grifo, F., D. Newman, A. S. Fairfleld, B. Bhattacharya, and J. T. Grupenhoff. 1997. The origins of prescription drugs. Pages 131–163 in F. Grifo and J. Rosenthal, eds. Biodiversity and human health. Island Press, Washington, D.C.
Guillaumet, J.-L., and J. Koechlln. 1971. Contribution a la definition des types de vegetation dans les regions tropicales (Exemple de Madagascar). Candollea 26:263–277.
Hedge, I. C, R. A. Clement, A. J. Paton, and P. B. Phillipson. 1998. Flore de Madagascar et des Comores, Famille 175—Labitae. Museum National d’Histoire Naturelle, Paris.
Humbert, H. 1959. Origines préumées et affinities de la flore de Madagascar. Mémoires de l’Institut Scientifique de Madagascar (Série B, Biologie Végétal) 9:149–187.
—, ed. 1963-present. Flore de Madagascar et des Comores. Museum National d’Histoire Naturelle, Paris.
King, S. R. 1994. Establishing reciprocity: Biodiversity conservation and new models for cooperation between forest dwelling people and the pharmaceutical industry. Pages 69–82 in T. Greaves, ed. Intellectual property rights for indigenous peoples: A sourcebook. The Society for Applied Anthropology, Oklahoma City.
Koechlin, J., J.-L. Guillaumet, and P. Morat. 1974. Flore et vegetation de Madagascar. J. Cramer, Vaduz.
Lewis, W. H., and M. P. Elvin-Lewis. 1995. Medicinal plants as sources of new therapeutics. Annals of the Missouri Botanical Garden 82:16–24.
Miller, J. S. 1996. Collecting methodologies for plant samples for pharmaceutical research. Pages 74–87 in T. F. Stuessy and S. H. Sohmer, eds. Sampling the green world. Columbia University Press,New York.
—,and S. J. Brewer. 1992. The discovery of medicines and forest conservation. Pages 119–134 in R. P. and J. E. Adams, eds. Conservation of plant genes: DNA banking and in vitro biotechnology. Academic Press, San Diego.
—,and R. E. Gereau. 2000. Therapeutic potential of plant-derived compounds: Realizing the potential. Pages 25–37 in S. J. and H. G. Cutler, eds. Biologically active natural product: Pharmaceuticals. CRC Press, Boca Raton.
Moerman, D. E. 1979. Symbols and selectivity: A statistical analysis of Native American medical ethnobotany. Journal of Ethnopharmacology 1:111–119.
—. 1991. The medicinal flora of native North America: An analysis. Journal of Ethnopharmacology 31:1–42.
—. 1996. An analysis of the food plants and drug plants of native North America. Journal of Ethnopharmacology 52:1–22.
Phillips, O., andA. H. Gentry. 1993. The useful plants of Tambopata, Peru: I. Statistical hypotheses tests with a new quantitative technique. Economic Botany 47:15–32.
Phillipson, P. B. 1994. Madagascar. Pages 271–281 in S. D. Davis, V. H. Heywood, and A. C. Hamilton, eds. Centres of Plant Diversity. A guide and strategy for their conservation. Vol. 1. Europe, Africa, South West Asia and the Middle East. IUCN Publications Unit, Cambridge.
Rodriguez, E., M. Aregullin, T. Nishida, S. Uehara, R. W. Wrangham, Z. Abramowski, A. Finlayson, andG. H. N. Towers. 1985. Thiarubine-A, a bioactive constituent ofAspilia (Asteraceae) consumed by wild chimpanzees. Experientia 41:419–420.
Schatz, G. E. 2000. Endemism in the Malagasy tree flora. Pages 1–9 in W. R. Lourenço and S. M. Goodman, eds. Diversité and endémisme à Madagascar. Mémoires de la Société de Biogéographie, Paris.
—. 2001. Generic tree flora of Madagascar. Royal Botanic Gardens, Kew and Missouri Botanical Garden, The Cromwell Press, U.K.
—,P. P. Lowry II,M. Lescot, A.-E. Wolf, S. Andriambololonera, V. Raharimalala, andJ. Raharimampionona. 1996. Conspectus of the vascular plants of Madagascar: A taxonomic and conservation electronic database. Pages 10–17 In L. J. G. van der Maesen, X. M. var der Burgt, and J. M. van Medenback de Rooy, eds. The biodiversity of African plants. Proceedings of the XIVth AETFAT Congress. Kluwer Academic Publishers, Dordrecht, The Netherlands.
Spjut, R. W. 1985. Limitations of a random screen: Search for new anticancer drugs in higher plants. Economic Botany 39:266–288.
Suffness, M., andJ. Douros. 1982. Current status of the NCI plant and animal product program. Journal of Natural Products 45:1–14.
Taylor, M. S. 1991. Flora and ethnobotany of Madagascar: Contributions towards a taxonomic bibliography. Missouri Botanical Garden, St. Louis.
—. 1991a. Flora and ethnobotany of Madagascar: Contributions towards a taxonomic bibliography— Supplement—December. Missouri Botanical Garden, St. Louis.
White, F. 1983. The vegetation of Africa. A descriptive memoire to accompany the UNESCO/AETFAT vegetation map of Africa. Natural Resources Research Series, No. 20. The UNESCO Press, Paris.
Wrangham, R. W., andT. Nishida. 1983.Aspilia spp. leaves: A puzzle in the feeding behavior of wild chimpanzees. Primates 24:276–282.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Miller, J.S., Bradley, A., Randrianasolo, A. et al. Sampling a diverse flora for novel biochemicals: An analysis of NCI collections from Madagascar. Econ Bot 59, 221–230 (2005). https://doi.org/10.1663/0013-0001(2005)059[0221:SADFFN]2.0.CO;2
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1663/0013-0001(2005)059[0221:SADFFN]2.0.CO;2